SARS CoV 2 News and Research

RSS

Study finds high levels of enteric pathogens in children from Alabama's rural areas, highlights sanitation issues

The study reveals a significant presence of enteric pathogens in children from Alabama's Black Belt region, linking well water consumption to increased pathogen detection and underscoring the need for improved sanitation infrastructure.

19 Nov 2023

Pigeon virus causes fatal neurological disease in young leukemia patient

A case report details a fatal neurologic disease in an immunocompromised toddler caused by pigeon avian paramyxovirus, underscoring the effectiveness of metagenomic testing in diagnosing complex infectious diseases.

19 Nov 2023

Lasting heart concerns in kids post-MIS-C: Study urges ongoing cardiac checks

Researchers evaluated the long-term cardiovascular effects in children after treatment for MIS-C, a condition linked to COVID-19. They found that regardless of initial heart injury, most children displayed persistent cardiac abnormalities, underscoring the importance of ongoing cardiac monitoring post-recovery.

16 Nov 2023

Coffee and COVID: Study finds coffee inhibits SARS-CoV-2, offers new dietary defense strategy

Study discovers that coffee, especially its bioactive compounds like chlorogenic acids, can inhibit SARS-CoV-2 entry and reduce ACE2 and TMPRSS2 levels, indicating that coffee intake might be a potential dietary strategy for COVID-19 prevention.

16 Nov 2023

Researchers develop easy-to-calculate scales to predict COVID-19 severity

Factors associated with hospital admissions, ICU stays and mortality in patients who have had SARS-CoV-2 are identified, and clinical prediction rules are developed.

16 Nov 2023

Exploring the dual role of nirmatrelvir and bisphosphonates in COVID-19 treatment and immunity

Review examines nirmatrelvir and bisphosphonates in treating COVID-19, revealing their impact on SARS-CoV-2-specific adaptive immunity and potential to mitigate severe infections, highlighting the need for balanced long-term immunity management.

16 Nov 2023

One in five patients on Nirmatrelvir–Ritonavir experience virologic rebound, new observational study reveals

The frequency of viral rebound (VR) among acute coronavirus disease 2019 patients.

16 Nov 2023

Senolytics show promise in combating brain aging and COVID-19 neuropathology

Study reveals that senolytics can reduce aging in human brain organoids and mitigate COVID-19 neuropathology, suggesting their potential as a therapeutic strategy against brain aging and coronavirus-related neurological complications.

15 Nov 2023

Autoimmune rheumatic disease patients benefit significantly from fourth COVID-19 vaccine dose

Patients with autoimmune rheumatic diseases, which include rheumatoid arthritis and other chronic disorders that cause inflammation, are at increased risk of SARS-CoV-2 infection, as well as death due to severe COVID-19.

15 Nov 2023

Call for global action to utilize genomic surveillance to address antimicrobial resistance

During the COVID-19 pandemic, genomic surveillance proved vital in helping understand the evolution and spread of the SARS-CoV-2 virus.

14 Nov 2023

Placental inflammation's role in adult depression and heart disease

An expression signature related to inflammation expressed in Hofbauer cells in the placenta, calculating polygenic risk scores to predict its expression.

14 Nov 2023

Study observes virologic rebound in 20% of COVID-19 patients treated with nirmatrelvir-ritonavir

An observational study of patients being treated for acute COVID-19 in a multicenter health care system observed virologic rebound in about 20 percent of patients treated with nirmatrelvir-ritonavir (N-R) versus about 2 percent of those who did not receive treatment. The findings are published in Annals of Internal Medicine.

13 Nov 2023

Study reveals coadministered COVID-19 and flu vaccines effective, especially in seniors

The study in JAMA Network Open evaluates the effectiveness of simultaneously administering the Pfizer-BioNTech BNT162b2 BA.4/5 COVID-19 vaccine and seasonal influenza vaccines versus separate administration. Results suggest similar or slightly increased COVID-19 outcomes and lower influenza-related outcomes with coadministration, particularly in those aged 65 and above.

13 Nov 2023

One in five individuals taking nirmatrelvir-ritonavir therapy found to experience rebound COVID

A new study by investigators from Mass General Brigham found that one in five individuals taking Nirmatrelvir-ritonavir therapy, commonly known as Paxlovid, to treat severe symptoms of COVID-19, experienced a positive test result and shedding of live and potentially contagious virus following an initial recovery and negative test - a phenomenon known as virologic rebound.

13 Nov 2023

Hospital-acquired COVID-19 mortality drops in Omicron era post-vaccination, reveals Swedish study

In a study published in JAMA Network Open, researchers found that hospital-acquired SARS-CoV-2 infections in Stockholm led to increased 30-day mortality in the pre-vaccination period but showed significantly lower mortality during the Omicron wave post-vaccination. The study underscores the importance of vaccination in reducing mortality risks from nosocomial SARS-CoV-2 infections.

13 Nov 2023

Non-invasive device detects Alzheimer's and Parkinson's biomarkers with high accuracy

An international team of researchers has developed a handheld, non-invasive device that can detect biomarkers for Alzheimer's and Parkinson's Diseases.

13 Nov 2023

Study reveals no neuroinflammation in long COVID patients with neuropsychiatric symptoms

In a JAMA Network Open study, researchers found no evidence of neuroinflammation or blood-brain barrier dysfunction in cerebrospinal fluid markers of individuals with post-COVID-19 condition and neuropsychiatric symptoms compared to controls. The study, which assessed cytokines, chemokines, and neuroinflammation markers, suggests that persistent central nervous system immune activation may not be the primary driver of neurological long COVID symptoms.

13 Nov 2023

Study uncovers how COVID-19 pandemic created new social disparities and affected existing inequalities

An article by Stockholm University researchers was recently published in the Proceedings of the National Academy of Sciences (PNAS).

13 Nov 2023

Study sheds light on role of antibodies in vaccine protection against COVID-19 variants

Efforts to contain the Covid-19 pandemic have largely focused on vaccine development and deployment. But how exactly do our immune systems respond to COVID-19 vaccines?

13 Nov 2023

Open-science triumph: Crowdsourced initiative yields potent SARS-CoV-2 antivirals

In this study, researchers harnessed crowdsourcing and open science to develop new antivirals against SARS-CoV-2, focusing on its main protease, Mpro. Their approach led to the discovery of potent compounds, including one with high efficacy in cell lines and cross-reactivity against various COVID-19 variants, demonstrating the potential of collaborative and transparent drug discovery in tackling global health crises.

12 Nov 2023

SARS CoV 2 News and Research

Study finds high levels of enteric pathogens in children from Alabama's rural areas, highlights sanitation issues

Pigeon virus causes fatal neurological disease in young leukemia patient

Lasting heart concerns in kids post-MIS-C: Study urges ongoing cardiac checks

Coffee and COVID: Study finds coffee inhibits SARS-CoV-2, offers new dietary defense strategy

Researchers develop easy-to-calculate scales to predict COVID-19 severity

Exploring the dual role of nirmatrelvir and bisphosphonates in COVID-19 treatment and immunity

One in five patients on Nirmatrelvir–Ritonavir experience virologic rebound, new observational study reveals

Senolytics show promise in combating brain aging and COVID-19 neuropathology

Autoimmune rheumatic disease patients benefit significantly from fourth COVID-19 vaccine dose

Call for global action to utilize genomic surveillance to address antimicrobial resistance

Placental inflammation's role in adult depression and heart disease

Study observes virologic rebound in 20% of COVID-19 patients treated with nirmatrelvir-ritonavir

Study reveals coadministered COVID-19 and flu vaccines effective, especially in seniors

One in five individuals taking nirmatrelvir-ritonavir therapy found to experience rebound COVID

Hospital-acquired COVID-19 mortality drops in Omicron era post-vaccination, reveals Swedish study

Non-invasive device detects Alzheimer's and Parkinson's biomarkers with high accuracy

Study reveals no neuroinflammation in long COVID patients with neuropsychiatric symptoms

Study uncovers how COVID-19 pandemic created new social disparities and affected existing inequalities

Study sheds light on role of antibodies in vaccine protection against COVID-19 variants

Open-science triumph: Crowdsourced initiative yields potent SARS-CoV-2 antivirals

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News